The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial
Abstract
CONTEXT: Polymyxin B fiber column is a medical device designed to reduce blood endotoxin levels in sepsis. Gram-negative-induced abdominal sepsis is likely associated with high circulating endotoxin. Reducing circulating endotoxin levels with polymyxin B hemoperfusion could potentially improve patient clinical outcomes. OBJECTIVE: To determine whether polymyxin B hemoperfusion added to conventional medical therapy improves clinical outcomes (mean arterial pressure [MAP], vasopressor requirement, oxygenation, organ dysfunction) and mortality compared with conventional therapy alone. DESIGN, SETTING, AND PATIENTS: A prospective, multicenter, randomized controlled trial (Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis [EUPHAS]) conducted at 10 Italian tertiary care intensive care units between December 2004 and December 2007. Sixty-four patients were enrolled with severe sepsis or septic shock who underwent emergency surgery for intra-abdominal infection. INTERVENTION: Patients were randomized to either conventional therapy (n=30) or conventional therapy plus 2 sessions of polymyxin B hemoperfusion (n=34). MAIN OUTCOME MEASURES: Primary outcome was change in MAP and vasopressor requirement, and secondary outcomes were PaO(2)/FIO(2) (fraction of inspired oxygen) ratio, change in organ dysfunction measured using Sequential Organ Failure Assessment (SOFA) scores, and 28-day mortality. RESULTS: MAP increased (76 to 84 mm Hg; P = .001) and vasopressor requirement decreased (inotropic score, 29.9 to 6.8; P < .001) at 72 hours in the polymyxin B group but not in the conventional therapy group (MAP, 74 to 77 mm Hg; P = .37; inotropic score, 28.6 to 22.4; P = .14). The PaO(2)/FIO(2) ratio increased slightly (235 to 264; P = .049) in the polymyxin B group but not in the conventional therapy group (217 to 228; P = .79). SOFA scores improved in the polymyxin B group but not in the conventional therapy group (change in SOFA, -3.4 vs -0.1; P < .001), and 28-day mortality was 32% (11/34 patients) in the polymyxin B group and 53% (16/30 patients) in the conventional therapy group (unadjusted hazard ratio [HR], 0.43; 95% confidence interval [CI], 0.20-0.94; adjusted HR, 0.36; 95% CI, 0.16-0.80). CONCLUSION: In this preliminary study, polymyxin B hemoperfusion added to conventional therapy significantly improved hemodynamics and organ dysfunction and reduced 28-day mortality in a targeted population with severe sepsis and/or septic shock from intra-abdominal gram-negative infections. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00629382.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Self-citation2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,018
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Serial Evaluation of the SOFA Score to Predict Outcome in Critically Ill Patients
Ferreira, F. L. (2001) · JAMA · doi:10.1001/jama.286.14.1754 · Cited by 2,862
Moreno, R., Vincent, J.-L., Matos, R., Mendonça, A., Cantraine, F., Thijs, L., Takala, J., Sprung, C., Antonelli, M., Bruining, H., et al. (1999) · Intensive Care Medicine · doi:10.1007/s001340050931 · Cited by 1,058
Self-citationWernovsky, G., Wypij, D., Jonas, R. A., Mayer, J. E., Hanley, F. L., Hickey, P. R., Walsh, A. Z., Chang, A. C., Castañeda, A. R., Newburger, J. W., et al. (1995) · Circulation · doi:10.1161/01.cir.92.8.2226 · Cited by 1,010
Noninvasive Positive-Pressure Ventilation for Respiratory Failure after Extubation
Esteban, A., Frutos-Vivar, F., Ferguson, N. D., Arabi, Y., Apezteguía, C., González, M., Epstein, S. K., Hill, N. S., Nava, S., Soares, M.-A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032736 · Cited by 894
Jones, A. E., Trzeciak, S., & Kline, J. A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819def97 · Cited by 850
Lau, W., Leung, T., Ho, S., Chan, M., Machin, D., Lau, J., Chan, A., Yeo, W., Mok, T., Yu, S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06475-7 · Cited by 409
Shoji, H. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00005.x · Cited by 370
Marshall, J. C., Foster, D., Vincent, J., Cook, D. J., Cohen, J., Dellinger, R. P., Opal, S., Abraham, E., Brett, S. J., Smith, T., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/422254 · Cited by 365
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Cruz, D. N., Perazella, M. A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V. M., et al. (2007) · Critical Care · doi:10.1186/cc5780 · Cited by 347
Self-citationVincent, J.-L., Laterre, P.-F., Cohen, J., Burchardi, H., Bruining, H., Lerma, F. A., Wittebole, X., De Backer, D., Brett, S., Marzo, D., et al. (2005) · Shock · doi:10.1097/01.shk.0000159930.87737.8a · Cited by 297
Shore, S., Nelson, D. P., Pearl, J. M., Manning, P. B., Wong, H., Shanley, T. P., Keyser, T., & Schwartz, S. M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01751-9 · Cited by 141
Newly Developed Immobilized Polymyxin B Fibers Improve the Survival of Patients with Sepsis
Nemoto, H., Nakamoto, H., Okada, H., Sugahara, S., Moriwaki, K., Arai, M., Kanno, Y., & Suzuki, H. (2001) · Blood Purification · doi:10.1159/000046966 · Cited by 118
Kushi, H., Miki, T., Okamaoto, K., Nakahara, J., Saito, T., & Tanjoh, K. (2005) · Critical Care · doi:10.1186/cc3815 · Cited by 110
Opal, S. M., & Glück, T. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00009 · Cited by 109
Zuppa, A. F., Nadkarni, V., Davis, L. A., Adamson, P. C., Helfaer, M. A., Elliott, M. R., Abrams, J., & Durbin, D. R. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000146133.52982.17 · Cited by 98
Nakamura, T., Ebihara, I., Shoji, H., Ushiyama, C., Suzuki, S., & Koide, H. (1999) · Inflammation Research · doi:10.1007/s000110050442 · Cited by 76
Uriu, K., Osajima, A., Hiroshige, K., Watanabe, H., Aibara, K., Inada, Y., Segawa, K., Anai, H., Takagi, I., Ito, A., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32767 · Cited by 73
Suzuki, H., Nemoto, H., Nakamoto, H., Okada, H., Sugahara, S., Kanno, Y., & Moriwaki, K. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00416.x · Cited by 65
Enomoto, N., Suda, T., Uto, T., Kato, M., Kaida, Y., Ozawa, Y., Miyazaki, H., Kuroishi, S., Hashimoto, D., Naito, T., et al. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01290.x · Cited by 64
Buchanan, D. R., & Miller, F. G. (2005) · Kennedy Institute of Ethics journal · doi:10.1353/ken.2005.0010 · Cited by 39
Nakamura, T., Ushiyama, C., Suzuki, Y., Inoue, T., Shoji, H., Shimada, N., & Koide, H. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1332 · Cited by 37
Nakamura, T., Ushiyama, C., Suzuki, Y., Shoji, H., Shimada, N., & Koide, H. (2002) · ASAIO Journal · doi:10.1097/00002480-200205000-00008 · Cited by 27
Randomized Trials Stopped Early for Benefit: A Systematic Review
Montori, V. M., Devereaux, P. J., Adhikari, N. K. J., Burns, K. E. A., Eggert, C. H., Briel, M., Lacchetti, C., Leung, T. W., Darling, E., Bryant, D. M., et al. (2005) · JAMA · doi:10.1001/jama.294.17.2203 · Cited by 26
Effect of polymyxin B-immobilized fiber on bone resorption in patients with sepsis
Nakamura, T., Kawagoe, Y., Matsuda, T., & Koide, H. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2357-7 · Cited by 25
Nakamura, T., Ushiyama, C., Suzuki, Y., Osada, S., Inoue, T., Shoji, H., Hara, M., Shimada, N., & Koide, H. (2003) · Nephron Clinical Practice · doi:10.1159/000071279 · Cited by 25
A targeted extracorporeal therapy for endotoxemia: the time has come
Kellum, J. A. (2007) · Critical Care · doi:10.1186/cc5918 · Cited by 13
Cited by
Cecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 818
Opal, S. M., Laterre, P.-F., Francois, B., LaRosa, S. P., Angus, D. C., Mira, J.-P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.2194 · Cited by 812
Metadata
- Authors
- Cruz, D. N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Bobbio Pallavicini, F. M., Rottoli, F., Giunta, F., & Ronco, C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-06-17
- Volume
- 301
- Issue
- 23
- Pages
- 2445
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2054107809
- Cited by
- 832
- References
- 32
- FWCI
- 35.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.